audit-pregnancy-medication-safety

Audit Pregnancy Medication Safety

Systematically review medications for fetal safety using established risk categories and evidence sources.

Why This Is Best Practice

Adopted by: FDA (PLLR 2015), ACOG, TERIS — the FDA replaced A/B/C/D/X categories with narrative PLLR labels in 2015 for prescription drugs; OTC drugs still commonly referenced by old categories. Impact: 90% of pregnant women take at least one medication during pregnancy (CDC 2012). Drug-related congenital anomalies account for ~1% of birth defects — most preventable with proper review (ACOG 2021). Conversely, undertreating serious conditions (epilepsy, depression, hypertension) causes greater harm than most medications. Why best: No drug is proven completely safe in pregnancy. Structured review weighs teratogenic risk against the risk of untreated disease.

Steps

1. Collect all medications: prescription, OTC, supplements, herbals — at every prenatal visit.
2. Apply ACOG's risk-benefit framework:
   • Risk of untreated maternal condition to fetus and mother
   • Risk of the medication to the fetus
   • Availability of safer alternatives
3. Established safe options (use as first line):
   • Analgesia: acetaminophen (avoid NSAIDs — see rules)
   • Nausea: doxylamine + B6 (Diclegis/Bonjesta); ginger; ondansetron (second line)
   • Heartburn: calcium carbonate antacids; famotidine; omeprazole (second trimester onward)
   • Allergy: loratadine, cetirizine (avoid first-trimester diphenhydramine)
   • Antibiotics: amoxicillin, azithromycin, cephalexin; avoid fluoroquinolones, tetracyclines
4. Avoid — evidence of harm:
   • NSAIDs (ibuprofen, naproxen): avoid after 20 weeks — cause fetal renal dysfunction and premature ductal closure
   • ACE inhibitors / ARBs: avoid all trimesters — renal dysgenesis, fetopathy
   • Isotretinoin (Accutane): absolutely contraindicated — causes severe fetal malformations; requires negative pregnancy test monthly
   • Warfarin: avoid first trimester and near delivery; use heparin/LMWH instead
   • Valproate: highest teratogenicity of all antiepileptics; neural tube defects 1–2%; avoid if possible
   • Methotrexate, misoprostol (therapeutic doses), thalidomide: absolutely contraindicated
5. Check before prescribing: use TERIS (teratogen database) or LactMed for evidence-based risk data.
6. Document decisions including risk-benefit rationale in chart.

Rules

• No aspirin >100 mg/day after 36 weeks (except prescribed low-dose protocol).
• Herbal supplements are not "safe because natural" — valerian, blue cohosh, pennyroyal have documented pregnancy risks.
• Most antiepileptic drugs require specialist review; do not switch or stop without neurology input — seizure risk may outweigh drug teratogenicity.

Examples

Migraine patient (first trimester): Acetaminophen 500–1,000 mg; avoid triptans in first trimester; avoid NSAIDs entirely; discuss with neurologist. Chronic hypertension on lisinopril: Switch to labetalol or nifedipine immediately — ACE inhibitors cause fetal renal failure.

Common Mistakes

• Assuming all OTC drugs are safe — ibuprofen is OTC and causes significant fetal harm after 20 weeks.
• Stopping psychiatric medication abruptly — untreated severe depression/anxiety causes more harm than SSRIs.
• Not checking supplements — fish oil in excess, vitamin A (retinol >10,000 IU), and licorice root are all harmful in pregnancy.

Health Disclaimer: This skill provides reference guidance only. Every medication decision in pregnancy requires individualized assessment by a licensed provider who can weigh your specific medical history, gestational age, and risk factors.